| Identification | Back Directory | [Name]
Seganserin | [CAS]
87729-89-3 | [Synonyms]
Seganserin
3-[2-[4-[Bis(4-fluorophenyl)methylene]piperidino]ethyl]-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one | [Molecular Formula]
C29H28F2N3O | [MOL File]
87729-89-3.mol | [Molecular Weight]
472.549 |
| Hazard Information | Back Directory | [Uses]
Seganserin is an orally active 5-HT receptor antagonist with a plasma half-life of 26.1 ± 12.9 (S.D.) h. Seganserin can be utilized in neurological research[1]. | [References]
[1] Dijk DJ, et al. Effects of seganserin, a 5-HT2 antagonist, and temazepam on human sleep stages and EEG power spectra. Eur J Pharmacol. 1989 Nov 21;171(2-3):207-18. DOI:10.1016/0014-2999(89)90109-x |
|
|